MIF and Alzheimer disease: The recent observations that the glycated and oxidized MIF found in the brain of AD patients [67] is unable to exert its activation function in glial cells, thus favoring plaque clearance, has suggested a new view on the role of MIF in AD, and more specifically that the augmented levels could be a compensatory attempt aimed at overcoming insufficient biological function.